CARsgen Therapeutics Holdings Limited (2171.HK) - Stock Prices, Stock Peers & Analysis

Home
2171.HK

Company Name	CARsgen Therapeutics Holdings Limited
Symbol	2171.HK
Currency	HKD
Price	4.79
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	2,737,676,600
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	2.48 - 11.88
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Zonghai Li M.D., Ph.D.
Website	https://www.carsgen.com

An error occurred while fetching data.

About CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States. The company is involved in developing CT053, an autologous CAR-T product candidate that is in